Yokohama
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Yokohama
Jun 30, 2024, 00:23 |
Blog
Abstract titles for ASCOBT24 are now available!
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: . "Abstract titles…
Jun 27, 2024, 03:08 |
Blog
Ruzanna Papyan: Attending the SIOP Asia Congress 2024 held in beautiful Yokohama was an absolute pleasure
Ruzanna Papyan shared on LinkedIn: . “Attending the SIOP Asia Congress 2024 held in…
May 16, 2024, 14:07 |
Blog
1 month left to register for the SIOP Asia Annual Congress
SIOP International recently shared on X/Twitter: “1 month left to register for the SIOP Asia Annual…
Apr 3, 2024, 06:29 |
Blog
Lillian Siu: Submit an abstract by 11:59 PM ET April 9 for ASCOBT24
Lillian Siu shared on X/Twitter: ''ASCOBT24, ASCO Aug 8-10, 2024 in Yokohama, Japan. Chaired by the…
Mar 23, 2024, 15:43 |
Societies
We received 375 abstracts from 28 countries - SIOP Asia
SIOP Asia posted on Facebook: "WOW! We received 375 abstracts from 28 countries! We are…
Aug 8, 2023, 18:09 |
Blog
Its an exciting time to be in cancer diagnostics - Chris Abbosh
Thank you American Society of Clinical Oncology (ASCO) and the ASCO Breakthrough 2023 organizers for an 💡 insightful…
Aug 6, 2023, 18:03 |
Societies
Brain, heart and stomach filled in ASCO Breakthrough 2023 - David D. W. Lee
An amazing 3 days of learning, sharing and networking. Brain, heart and stomach filled in…
Aug 4, 2023, 09:15 |
Blog
10 Tweets from ASCOBT23 not to miss
ASCO Breakthrough (ASCOBT23) is being held in Yokohama, Japan, and online from August 3 to…
Aug 1, 2023, 18:35 |
Blog
Authors of accepted abstracts will be given opportunity and guidance by mentors and peers to develop their research into a paper - Herbert Loong
Looking forward to the ASCO in Yokohama (Japan) and the much anticipated manuscript development workshop chaired by…
All:
9
Posts:
1 - 10
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Facebook
RSS Feed
Twitter
Linkedin
Youtube